It is the largest biotech event organized by a national bioindustry association in Europe being 34% of our delegates from outside of Spain.
The next Biospain will start in a month and will take place at the Fira Internacional de Barcelona. It is said that the city of Barcelona is the main biotech cluster in Spain and one of the most dynamic cities in the world. VIVEbiotech will be a bronze sponsor of the congress.
During Biospain, VIVEbiotech will lead a panel entitled “Lentiviral vectors for gene and gene-modified cell therapies” in which speakers from top international companies will participate. It will take place on Tuesday, September 26, and will be moderated by Gurutz Linazasoro, CEO of VIVEbiotech. Natalia Elizalde, Chief Business Development Officer at VIVEbiotech, Joost van den Berg from CellPoint, Pierre Charneau from Theravectys and Institut Pasteur, and Pablo Menendez from OneChain Immunotherapeutics, Josep Carreras Leukaemia Research Institute and ICREA – Institució Catalana de Recerca i Estudis Avançats will participate in it. You can find more details about the program here: https://biospain2023.org/program/
Gurutz has been interviewed by AseBio about the main challenges faced by advanced therapies, which are the main pillars of personalized and precision medicine. You can read the full interview here: https://www.asebio.com/en/news-events/news/biospain2023interview-global-effort-must-be-made-make-advanced-therapies
Search for VIVEbiotech on the partnering platform and schedule a meeting with us.